Skip to main content
Erschienen in: Journal of Neurology 4/2020

04.01.2020 | Original Communication

Dynamics of impulsive–compulsive behaviors in early Parkinson’s disease: a prospective study

verfasst von: Vladana Marković, Iva Stanković, Igor Petrović, Tanja Stojković, Nataša Dragašević-Mišković, Saša Radovanović, Marina Svetel, Elka Stefanova, Vladimir Kostić

Erschienen in: Journal of Neurology | Ausgabe 4/2020

Einloggen, um Zugang zu erhalten

Abstract

Introduction

Impulsive compulsive behaviors (ICBs) in Parkinson’s disease (PD) are debilitating disorders of repetitive, excessive, and compulsive nature affecting up to one third of PD patients. Objectives are to address clinical, psychiatric, and cognitive characteristics of ICBs and to define risk factors in PD patients in the initial motor stage, followed up for 5 years.

Methods

We analyzed 106 consecutive PD outpatients at Hoehn and Yahr disease stage 1 and 125 healthy controls. The participants were assessed for the presence of any ICB using the current clinical criteria and underwent comprehensive clinical, psychiatric, and neuropsychological evaluations. The patients completed the same protocol at Years 1, 2, 3, and 5.

Results

ICBs were present in 21 (19.8%) PD patients and 13 (10.4%) healthy controls at baseline. Prevalence of ICBs increased to 29.2% at Year 5, significantly after Year 2. Multiple ICBs were present in 4,7% and 61.9% of PD-ICBs at the baseline and Year 5, respectively. ICBs resolved in 30% of cases (most often compulsive eating). Dopamine agonist treatment at the baseline carried five times higher risk of having or developing ICB(s) anytime during follow-up. We identified risk factors for compulsive eating (dopamine agonist treatment at baseline), hypersexuality (males), compulsive buying (depression and younger age), and punding (younger age and higher levodopa dose at baseline). Significant interaction of rate of motor progression and ICB diagnosis was shown.

Conclusions

PD patients showed increasing frequency of most ICBs during the 5-year follow-up. Specific risk factors were identified for different types of ICBs.
Literatur
1.
Zurück zum Zitat Weintraub D, David AS, Evans AH, Grant JE, Stacy M (2015) Clinical spectrum of impulse control disorders in Parkinson's disease. Mov Disord 30:121–127CrossRef Weintraub D, David AS, Evans AH, Grant JE, Stacy M (2015) Clinical spectrum of impulse control disorders in Parkinson's disease. Mov Disord 30:121–127CrossRef
2.
Zurück zum Zitat Evans AH, Lees AJ (2004) Dopamine dysregulation syndrome in Parkinson's disease. Curr Opin Neurol 17:393–398CrossRef Evans AH, Lees AJ (2004) Dopamine dysregulation syndrome in Parkinson's disease. Curr Opin Neurol 17:393–398CrossRef
3.
Zurück zum Zitat Weintraub D, Koester J, Potenza MN, Siderowf AD, Stacy M, Voon V, Whetteckey J, Wunderlich GR, Lang AE (2010) Impulse control disorders in Parkinson disease: a cross-sectional study of 3090 patients. Arch Neurol 67:589–595CrossRef Weintraub D, Koester J, Potenza MN, Siderowf AD, Stacy M, Voon V, Whetteckey J, Wunderlich GR, Lang AE (2010) Impulse control disorders in Parkinson disease: a cross-sectional study of 3090 patients. Arch Neurol 67:589–595CrossRef
4.
Zurück zum Zitat Fan W, Ding H, Ma J, Chan P (2009) Impulse control disorders in Parkinsons disease in a Chinese population. Neurosci Lett 465:6–9CrossRef Fan W, Ding H, Ma J, Chan P (2009) Impulse control disorders in Parkinsons disease in a Chinese population. Neurosci Lett 465:6–9CrossRef
5.
Zurück zum Zitat Antonini A, Barone P, Bonuccelli U, Annoni K, Asgharnejad M, Stanzione P (2017) ICARUS study: prevalence and clinical features of impulse control disorders in Parkinson's disease. J Neurol Neurosurg Psychiatry 88:317–324CrossRef Antonini A, Barone P, Bonuccelli U, Annoni K, Asgharnejad M, Stanzione P (2017) ICARUS study: prevalence and clinical features of impulse control disorders in Parkinson's disease. J Neurol Neurosurg Psychiatry 88:317–324CrossRef
6.
Zurück zum Zitat Sharma A, Goyal V, Behari M, Srivastva A, Shukla G, Vibha D (2015) Impulse control disorders and related behaviours (ICD-RBs) in Parkinson's disease patients: Assessment using "Questionnaire for impulsive-compulsive disorders in Parkinson's disease" (QUIP). Ann Indian Acad Neurol 18:49–59CrossRef Sharma A, Goyal V, Behari M, Srivastva A, Shukla G, Vibha D (2015) Impulse control disorders and related behaviours (ICD-RBs) in Parkinson's disease patients: Assessment using "Questionnaire for impulsive-compulsive disorders in Parkinson's disease" (QUIP). Ann Indian Acad Neurol 18:49–59CrossRef
7.
Zurück zum Zitat Voon V, Sohr M, Lang AE, Potenza MN, Siderowf AD, Whetteckey J, Weintraub D, Wunderlich GR, Stacy M (2011) Impulse control disorders in Parkinson disease: a multicenter case- control study. Ann Neurol 69:986–996CrossRef Voon V, Sohr M, Lang AE, Potenza MN, Siderowf AD, Whetteckey J, Weintraub D, Wunderlich GR, Stacy M (2011) Impulse control disorders in Parkinson disease: a multicenter case- control study. Ann Neurol 69:986–996CrossRef
8.
Zurück zum Zitat Kon T, Ueno T, Haga R, Tomiyama M (2018) The factors associated with impulse control behaviors in Parkinson's disease: a 2-year longitudinal retrospective cohort study. Brain Behav 8:e01036CrossRef Kon T, Ueno T, Haga R, Tomiyama M (2018) The factors associated with impulse control behaviors in Parkinson's disease: a 2-year longitudinal retrospective cohort study. Brain Behav 8:e01036CrossRef
9.
Zurück zum Zitat Corvol JC, Artaud F, Cormier-Dequaire F, Rascol O, Durif F, Derkinderen P, Marques AR, Bourdain F, Brandel JP, Pico F, Lacomblez L, Bonnet C, Brefel-Courbon C, Ory-Magne F, Grabli D, Klebe S, Mangone G, You H, Mesnage V, Lee PC, Brice A, Vidailhet M, Elbaz A, DIGPD Study Group (2018) Longitudinal analysis of impulse control disorders in Parkinson disease. Neurology 91:e189–e201CrossRef Corvol JC, Artaud F, Cormier-Dequaire F, Rascol O, Durif F, Derkinderen P, Marques AR, Bourdain F, Brandel JP, Pico F, Lacomblez L, Bonnet C, Brefel-Courbon C, Ory-Magne F, Grabli D, Klebe S, Mangone G, You H, Mesnage V, Lee PC, Brice A, Vidailhet M, Elbaz A, DIGPD Study Group (2018) Longitudinal analysis of impulse control disorders in Parkinson disease. Neurology 91:e189–e201CrossRef
10.
Zurück zum Zitat Prange S, Danaila T, Laurencin C, Caire C, Metereau E, Merle H, Broussolle E, Maucort-Boulch D, Thobois S (2019) Age and time course of long-term motor and nonmotor complications in Parkinson disease. Neurology 92:e148–e160CrossRef Prange S, Danaila T, Laurencin C, Caire C, Metereau E, Merle H, Broussolle E, Maucort-Boulch D, Thobois S (2019) Age and time course of long-term motor and nonmotor complications in Parkinson disease. Neurology 92:e148–e160CrossRef
11.
Zurück zum Zitat Hughes A, Daniel S, Kilford L, Lees A (1992) Accuracy of clinical diagnosis of idiopathic Parkinson’s disease: a clinico-pathological study of 100 cases. J Neurol 55:181–184 Hughes A, Daniel S, Kilford L, Lees A (1992) Accuracy of clinical diagnosis of idiopathic Parkinson’s disease: a clinico-pathological study of 100 cases. J Neurol 55:181–184
12.
Zurück zum Zitat Hoehn MM, Yahr MD (1967) Parkinsonism: onset, progression and mortality. Neurology 17:427–442CrossRef Hoehn MM, Yahr MD (1967) Parkinsonism: onset, progression and mortality. Neurology 17:427–442CrossRef
13.
Zurück zum Zitat Dubois B, Burn D, Goetz C, Aarsland D, Brown RG, Broe GA, Dickson D, Duyckaerts C, Cummings J, Gauthier S, Korczyn A, Lees A, Levy R, Litvan I, Mizuno Y, McKeith IG, Olanow CW, Poewe W, Sampaio C, Tolosa E, Emre M (2007) Diagnostic procedures for Parkinson's disease dementia: recommendations from the movement disorder society task force. Mov Disord 22:2314–2324CrossRef Dubois B, Burn D, Goetz C, Aarsland D, Brown RG, Broe GA, Dickson D, Duyckaerts C, Cummings J, Gauthier S, Korczyn A, Lees A, Levy R, Litvan I, Mizuno Y, McKeith IG, Olanow CW, Poewe W, Sampaio C, Tolosa E, Emre M (2007) Diagnostic procedures for Parkinson's disease dementia: recommendations from the movement disorder society task force. Mov Disord 22:2314–2324CrossRef
14.
Zurück zum Zitat American Psychiatric Association (2000) Diagnostic and statistical manual of mental disorders, American Psychiatric Association, Washington American Psychiatric Association (2000) Diagnostic and statistical manual of mental disorders, American Psychiatric Association, Washington
15.
Zurück zum Zitat Voon V, Hassan K, Zurowski M, de Souza M, Thomsen T, Fox S, Lang AE, Miyasaki J (2006) Prevalence of repetitive and reward-seeking behaviors in Parkinson disease. Neurology 67:1254–1257CrossRef Voon V, Hassan K, Zurowski M, de Souza M, Thomsen T, Fox S, Lang AE, Miyasaki J (2006) Prevalence of repetitive and reward-seeking behaviors in Parkinson disease. Neurology 67:1254–1257CrossRef
16.
Zurück zum Zitat McElroy SL, Keck PE Jr, Pope HG Jr, Smith JM, Strakowski SM (1994) Compulsive buying: a report of 20 cases. J Clin Psychiatry 55:242–248PubMed McElroy SL, Keck PE Jr, Pope HG Jr, Smith JM, Strakowski SM (1994) Compulsive buying: a report of 20 cases. J Clin Psychiatry 55:242–248PubMed
17.
Zurück zum Zitat Evans AH, Katzenschlager R, Paviour D, O'Sullivan JD, Appel S, Lawrence AD, Lees AJ (2004) Punding in Parkinson's disease: its relation to the dopamine dysregulation syndrome. Mov Disord 19:397–405CrossRef Evans AH, Katzenschlager R, Paviour D, O'Sullivan JD, Appel S, Lawrence AD, Lees AJ (2004) Punding in Parkinson's disease: its relation to the dopamine dysregulation syndrome. Mov Disord 19:397–405CrossRef
18.
Zurück zum Zitat Giovannoni G, O'Sullivan JD, Turner K, Manson AJ, Lees AJ (2000) Hedonistic homeostatic dysregulation in patients with Parkinson's disease on dopamine replacement therapies. J Neurol Neurosurg Psychiatry 68:423–428CrossRef Giovannoni G, O'Sullivan JD, Turner K, Manson AJ, Lees AJ (2000) Hedonistic homeostatic dysregulation in patients with Parkinson's disease on dopamine replacement therapies. J Neurol Neurosurg Psychiatry 68:423–428CrossRef
19.
Zurück zum Zitat Weintraub D, Hoops S, Shea JA, Lyons KE, Pahwa R, Driver-Dunckley ED, Adler CH, Potenza MN, Miyasaki J, Siderowf AD, Duda JE, Hurtig HI, Colcher A, Horn SS, Stern MB, Voon V (2009) Validation of the questionnaire for impulsive-compulsive disorders in Parkinson's disease. Mov Disord 24:1461–1467CrossRef Weintraub D, Hoops S, Shea JA, Lyons KE, Pahwa R, Driver-Dunckley ED, Adler CH, Potenza MN, Miyasaki J, Siderowf AD, Duda JE, Hurtig HI, Colcher A, Horn SS, Stern MB, Voon V (2009) Validation of the questionnaire for impulsive-compulsive disorders in Parkinson's disease. Mov Disord 24:1461–1467CrossRef
20.
Zurück zum Zitat Goetz CG, Tilley BC, Shaftman SR, Stebbins GT, Fahn S, Martinez-Martin P, Poewe W, Sampaio C, Stern MB, Dodel R, Dubois B, Holloway R, Jankovic J, Kulisevsky J, Lang AE, Lees A, Leurgans S, LeWitt PA, Nyenhuis D, Olanow CW, Rascol O, Schrag A, Teresi JA, van Hilten JJ, LaPelle N, Movement Disorder Society UPDRS Revision Task Force (2008) Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results. Mov Disord 23:2129–2170CrossRef Goetz CG, Tilley BC, Shaftman SR, Stebbins GT, Fahn S, Martinez-Martin P, Poewe W, Sampaio C, Stern MB, Dodel R, Dubois B, Holloway R, Jankovic J, Kulisevsky J, Lang AE, Lees A, Leurgans S, LeWitt PA, Nyenhuis D, Olanow CW, Rascol O, Schrag A, Teresi JA, van Hilten JJ, LaPelle N, Movement Disorder Society UPDRS Revision Task Force (2008) Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results. Mov Disord 23:2129–2170CrossRef
21.
Zurück zum Zitat Tomlinson CL, Stowe R, Patel S, Rick C, Gray R, Clarke CE (2010) Systematic review of levodopa dose equivalency reporting in Parkinson's disease. Mov Disord 25:2649–2653CrossRef Tomlinson CL, Stowe R, Patel S, Rick C, Gray R, Clarke CE (2010) Systematic review of levodopa dose equivalency reporting in Parkinson's disease. Mov Disord 25:2649–2653CrossRef
22.
Zurück zum Zitat Mioshi E, Dawson K, Mitchell J, Arnold R, Hodges JR (2006) The Addenbrooke's Cognitive Examination Revised (ACE-R): a brief cognitive test battery for dementia screening. Int J Geriat Psychiatry 21:1078–1085CrossRef Mioshi E, Dawson K, Mitchell J, Arnold R, Hodges JR (2006) The Addenbrooke's Cognitive Examination Revised (ACE-R): a brief cognitive test battery for dementia screening. Int J Geriat Psychiatry 21:1078–1085CrossRef
23.
Zurück zum Zitat Cooper J, Sagar HJ, Jordan N, Harvey NS, Sullivan EV (1991) Cognitive impairment in early, untreated Parkinson's disease and its relationship to motor disability. Brain 114:2095–2212CrossRef Cooper J, Sagar HJ, Jordan N, Harvey NS, Sullivan EV (1991) Cognitive impairment in early, untreated Parkinson's disease and its relationship to motor disability. Brain 114:2095–2212CrossRef
24.
Zurück zum Zitat Hooper HE (1958) The Hooper visual organization test. Western Psychological Service, Los Angeles Hooper HE (1958) The Hooper visual organization test. Western Psychological Service, Los Angeles
25.
Zurück zum Zitat Starkstein SE, Mayberg HS, Preziosi TJ, Andrezejewski P, Leiguarda R, Robinson RG (1992) Reliability, validity, and clinical correlates of apathy in Parkinson's disease. J Neuropsych Clin Neurosci 4:134–139CrossRef Starkstein SE, Mayberg HS, Preziosi TJ, Andrezejewski P, Leiguarda R, Robinson RG (1992) Reliability, validity, and clinical correlates of apathy in Parkinson's disease. J Neuropsych Clin Neurosci 4:134–139CrossRef
26.
Zurück zum Zitat Weintraub D, Papay K, Siderowf A (2013) Parkinson's progression markers initiative. Screening for impulse control symptoms in patients with de novo Parkinson disease: a case-control study. Neurology 80:176–180CrossRef Weintraub D, Papay K, Siderowf A (2013) Parkinson's progression markers initiative. Screening for impulse control symptoms in patients with de novo Parkinson disease: a case-control study. Neurology 80:176–180CrossRef
27.
Zurück zum Zitat Smith KM, Xie SX, Weintraub D (2016) Incident impulse control disorder symptoms and dopamine transporter imaging in Parkinson disease. J Neurol Neurosurg Psychiatry 87:864–870CrossRef Smith KM, Xie SX, Weintraub D (2016) Incident impulse control disorder symptoms and dopamine transporter imaging in Parkinson disease. J Neurol Neurosurg Psychiatry 87:864–870CrossRef
28.
Zurück zum Zitat Fasano A, Petrovic I (2010) Insights into pathophysiology of punding reveal possible treatment strategies. Mol Psychiatry 15:560–573CrossRef Fasano A, Petrovic I (2010) Insights into pathophysiology of punding reveal possible treatment strategies. Mol Psychiatry 15:560–573CrossRef
29.
Zurück zum Zitat Martini A, Weis L, Fiorenzato E, Schifano R, Cianci V, Antonini A, Biundo R (2019) Impact of cognitive profile on impulse control disorders presence and severity in Parkinson's disease. Front Neurol 10:266CrossRef Martini A, Weis L, Fiorenzato E, Schifano R, Cianci V, Antonini A, Biundo R (2019) Impact of cognitive profile on impulse control disorders presence and severity in Parkinson's disease. Front Neurol 10:266CrossRef
30.
Zurück zum Zitat Martini A, Dal Lago D, Edelstyn NMJ, Grange JA, Tamburin S (2018) Impulse control disorder in Parkinson's disease: a meta-analysis of cognitive, affective, and motivational Correlates. Front Neurol 9:654CrossRef Martini A, Dal Lago D, Edelstyn NMJ, Grange JA, Tamburin S (2018) Impulse control disorder in Parkinson's disease: a meta-analysis of cognitive, affective, and motivational Correlates. Front Neurol 9:654CrossRef
Metadaten
Titel
Dynamics of impulsive–compulsive behaviors in early Parkinson’s disease: a prospective study
verfasst von
Vladana Marković
Iva Stanković
Igor Petrović
Tanja Stojković
Nataša Dragašević-Mišković
Saša Radovanović
Marina Svetel
Elka Stefanova
Vladimir Kostić
Publikationsdatum
04.01.2020
Verlag
Springer Berlin Heidelberg
Erschienen in
Journal of Neurology / Ausgabe 4/2020
Print ISSN: 0340-5354
Elektronische ISSN: 1432-1459
DOI
https://doi.org/10.1007/s00415-019-09692-4

Weitere Artikel der Ausgabe 4/2020

Journal of Neurology 4/2020 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.